HomeDNLI • NASDAQ
add
Denali Therapeutics Inc
Previous close
$14.82
Day range
$14.17 - $14.80
Year range
$10.57 - $33.32
Market cap
2.07B USD
Avg Volume
2.00M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 119.78M | 17.16% |
Net income | -124.12M | -25.34% |
Net profit margin | — | — |
Earnings per share | -0.72 | -22.03% |
EBITDA | -131.01M | -14.27% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 898.95M | 0.32% |
Total assets | 1.17B | -22.38% |
Total liabilities | 139.19M | 20.49% |
Total equity | 1.03B | — |
Shares outstanding | 146.21M | — |
Price to book | 2.10 | — |
Return on assets | -27.68% | — |
Return on capital | -30.00% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -124.12M | -25.34% |
Cash from operations | -75.30M | 17.45% |
Cash from investing | 157.94M | 60.23% |
Cash from financing | 1.62M | -75.98% |
Net change in cash | 84.26M | 497.38% |
Free cash flow | -34.47M | 36.96% |
About
Founded
2013
Headquarters
Website
Employees
486
